Questions on fecal calprotectin's usefulness as a measure of intestinal inflammation in inflammatory bowel disease (IBD) dominated the viewer chat after the opening session of Advances in Inflammatory ...

Gastrointestinal biomarker tests enhance patient diagnosis of IBD and pancreatic insufficiency on leading clinical chemistry platforms SAN DIEGO, July 14, 2025 /PRNewswire/ -- QuidelOrtho Corporation ...

Medically reviewed by Robert Burakoff, MD Key Takeaways Diagnosing Crohn's disease can involve multiple tests, including ...

Results obtained through fecal immunochemical tests and levels of fecal calprotectin could help identify patients with ulcerative colitis with endoscopic markers of disease severity, according to ...

The FDA has cleared a fully automated random access calprotectin assay to assist in the diagnosis of inflammatory bowel disease in the U.S., the manufacturer announced. The Quanta Flash Calprotectin ...

Patients presenting with persistent abdominal pain and diarrhea are common in clinical practice. Evaluation of these patients, assuming no alarm symptoms, can be difficult. Inflammatory bowel disease ...

Background and aims: Fecal calprotectin (FC) is a recognized marker of intestinal inflammation, previously validated in different clinical settings. Recent studies have suggested its uselfulness in ...

Age, fecal calprotectin level, toxin B polymerase chain reaction cycle threshold, immunosuppression, sex, and creatinine levels were identified as independent risk factors for developing recurrent ...

Two biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease (IBD), but gastroenterologists are hoping to gain even more insight from ...

Stool tests are vital for early detection of serious gastrointestinal diseases, including colorectal cancer, where timely intervention significantly improves survival rates. These tests also identify ...